Clinical Trial Update: Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating palifermin in combination with leuprolide acetate to promote immune recovery after total body irradiation-based, T-cell deplet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Multiple Myeloma
• Myelodysplastic Syndrome
• Non-hodgkin Lymphoma

Drugs mentioned

• Leuprolide acetate (Leuprolide acetate)
• Palifermin (palifermin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia, Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING